CPT-11 and L-OHP combination versus alternated combination of LV5FU2+CPT-11/LV5FU2+L-OHP in 5-FU resistant advanced colorectal cancer (CRC): Preliminary results

被引：1
|
作者：
Becouam, Y
Mousseau, M
Gamelin, E
Coudert, B
Marceau-Suissa, J
Bekradda, M
机构：
[1] Inst Bergonie Bordeaux, Bordeaux, France
[2] CHU Grenoble, F-38043 Grenoble, France
[3] Ctr Paul Papin, Angers, France
[4] Ctr F Leclerc, Dijon, France
[5] Rhone Poulenc Rorer, Montrouge, France
[6] C&AC Kremlin Bicetre, Le Kremlin Bicetre, France
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80652-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
219
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [1] Sequential administration of 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) at relapse versus CPT-11 followed by 5-FU/LV in advanced colorectal carcinoma - A phase III randomized study
    Tsavaris, Nicolas
    Kosmas, Christos
    Skopelitis, Helias
    Papadoniou, Nicitas
    Polyzos, Aristidis
    Zografos, George
    Adoniou, Efstathios
    Gryniatsos, John
    Felekouras, Evangelos
    Zacharakis, Michalis
    Sigala, Francheska
    Bacoyiannis, Christos
    Papastratis, George
    Papalambros, Efstathios
    CHEMOTHERAPY, 2007, 53 (04) : 282 - 291
  • [2] 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) versus CPT-11 followed by 5-FU/LV at relapse in patients with advanced colorectal carcinoma. Phase III randomized study
    Tsavaris, N.
    Kosmas, C.
    Skopelitis, E.
    Papadoniou, N.
    Polyzos, A.
    Zografos, G.
    Diamartis, N.
    Ntokou, A.
    Tsaousi, S.
    Sarantonis, I
    Adoniou, E.
    Gryniatsos, J.
    Felekouras, E.
    Papalambros, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 81 - 81
  • [3] Oxaliplatin (L-OHP) in combination with leucovorin (LV) and 5-fluorouracil (5FU) in pretreated metastatic colorectal cancer (CRC) patients (PTS).
    Di Stefano, A
    Calandri, C
    Benedetti, G
    Poggi, B
    Mazzoni, F
    Marrocolo, F
    Spagnuolo, P
    Rimondini, S
    Crinò, L
    ANNALS OF ONCOLOGY, 2000, 11 : 68 - 68
  • [4] CPT-11/5-fluorouracil(5-FU)/leucchorin (FA)/oxaliplatin (L-OHP) (CPT-11-FFL) plus cetuximab (Cmab) in unselectecl advanced colorectal cancer (ACC) patients.
    Garufi, C.
    Torsello, A.
    Campanella, C.
    Ettorre, G. M.
    Vennarecci, G.
    Melucci, E.
    Zeuli, M.
    Sperduti, I.
    Gelibter, A.
    Cognetti, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Oxaliplatin (L-OHP) in combination with leucovorin and bolus-continuous infusion 5fluorouracil (LV5FU2) in advanced colorectal cancer (ACC) pretreated with 5FU
    Beretta, GD
    Cascinu, S
    Zaniboni, A
    Ratti, R
    Giordani, P
    Catalano, V
    Martignoni, G
    Barni, S
    Frontini, L
    Labianca, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S80 - S80
  • [6] Pilot trial of 5-FU/oxaliplatin (CIFOX) for patients with metastatic colorectal cancer who progressed on 5-FU/LV/CPT-11 (IFL).
    Aparicio, A
    Iqbal, S
    Yang, D
    Groshen, S
    Park, D
    Garcia, A
    Lenz, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 312S - 312S
  • [7] Weekly administration of 5-fluorouracil (5-FU), folinic acid (FA), oxaliplatin (L-OHP) and irinotecan (CPT-11) [FUFOXIRI] for patients with metastatic gastric or colorectal cancer
    Harba, A
    Peinert, S
    Grothe, W
    Jordan, K
    Kegel, T
    Mueller, LP
    Behrens, R
    Grothey, A
    Arnold, D
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 300S - 300S
  • [8] CETUXIMAB (CMAB) PLUS CPT-11/5-FLUOROURACIL (5-FU)/LEUCOVORIN(FA)/OXALIPLATIN (L-OHP) (CPT-11-FFL) IN UNRESECTABLE COLORECTAL LIVER METASTASES (CLM): POCHER TRIAL TOXICITY RESULTS
    Torsello, A.
    Garufi, C.
    Tumolo, S.
    Mottolese, M.
    Campanella, C.
    Zeuli, M.
    Sperduti, I
    Pizzi, G.
    Ettorre, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 62 - 63
  • [9] RESECTABILITY OF COLORECTAL LIVER METASTASES (CLM) WITH CETUXIMAB PLUS CPT-11/5-FLUOROURACIL (5-FU)/LEUCOVORIN(FA)/OXALIPLATIN (L-OHP) (CPT-11-FFL) AS NEOADJUVANT TREATMENT (POCHER TRIAL)
    Torsello, A.
    Garufi, C.
    Tumolo, S.
    Melucci, E.
    Conti, S.
    Campanella, C.
    Zeuli, M.
    Pizzi, G.
    Tropea, G.
    Sperduti, I
    Ettorre, G. M.
    Cognetti, F.
    ANNALS OF ONCOLOGY, 2009, 20
  • [10] TIMED-FLAT-INFUSION (TFI) OF 5-FLUOROURACIL (5-FU) PLUS WEEKLY ALTERNATING IRINOTECAN (CPT-11) AND OXALIPLATIN (L-OHP) IN ADVANCED COLORECTAL CANCER: PRELIMINARY RESULTS OF A DOSE-FINDING STUDY
    Morelli, M. F.
    Ricevuto, E.
    Calista, F.
    Gugliemi, F.
    Cannita, K.
    Rispoli, A. I.
    Santomaggio, A.
    Porzio, G.
    Lanfiuti, P.
    Mancini, M.
    Marchetti, P.
    Ficorella, C.
    ANNALS OF ONCOLOGY, 2004, 15 : 64 - 64
12345